Chapon Catherine, Jackson Johanna S, Aboagye Eric O, Herlihy Amy H, Jones William A, Bhakoo Kishore K
MRC Clinical Sciences Centre, Imperial College London, UK.
Mol Imaging Biol. 2009 Jan-Feb;11(1):31-8. doi: 10.1007/s11307-008-0174-z. Epub 2008 Sep 5.
PURPOSE: The purpose of the study is to track iron-oxide nanoparticle-labelled adult rat bone marrow-derived stem cells (IO-rBMSCs) by magnetic resonance imaging (MRI) and determine their effect in host cardiac tissue using 2-deoxy-2-[F-18]fluoro-D: -glucose-positron emission tomography (FDG-PET). PROCEDURES: Infarcted rats were randomised to receive (1) live IO-rBMSCs by direct local injection, or (2) dead IO-rBMSCs as controls; (3) sham-operated rats received live IO-rBMSCs. The rats were then imaged from 2 days to 6 weeks post-cell implantation using both MRI at 9.4T and FDG-PET. RESULTS: Implanted IO-rBMSCs were visible in the heart by MRI for the duration of the study. Histological analysis confirmed that the implanted IO-rBMSCs were present for up to 6 weeks post-implantation. At 1 week post-IO-rBMSC transplantation, PET studies demonstrated an increase in FDG uptake in infarcted regions implanted with live IO-rBMSC compared to controls. CONCLUSIONS: Noninvasive multimodality imaging allowed us to visualise IO-rBMSCs and establish their affect on cardiac function in a rat model of myocardial infarction (MI).
Med Biol Eng Comput. 2017-12-1
Circ Cardiovasc Imaging. 2017-4
Int J Nanomedicine. 2014-3-31
Biomed Res Int. 2014
J Cardiovasc Magn Reson. 2014-1-10
Theranostics. 2013-7-20
Am J Nucl Med Mol Imaging. 2013-7-10
Proc Natl Acad Sci U S A. 2005-8-9
Int J Cardiovasc Imaging. 2004-12
Magn Reson Med. 2004-11